Quince Therapeutics, Inc. Common Stock (QNCX)
Since Feb 02, 2022, Quince Therapeutics, Inc. Common Stock (QNCX) has reported earnings 12 times. On average the shares move ±12.77% post-earnings, with a positive reaction 33.3% of the time. Its largest post-earnings gain was +18.89% (Nov 13, 2024) and its largest decline was -61.49% (Feb 12, 2026). The next earnings report is predicted for 2026-07-15 (high confidence).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
12
Avg Abs. Movement
±12.77%
Positive %
33.3%
Negative %
66.7%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | ☀ PRE | $0.39 | $0.41 | $0.23 | 1,020,743 | -61.49% | open_in_new |
| Nov 12, 2025 | ☽ POST | $1.79 | $1.80 | $1.72 | 7,010 | -2.62% | open_in_new |
| Aug 11, 2025 | ☽ POST | $1.63 | $1.65 | $1.59 | 4,414 | +15.72% | open_in_new |
| May 13, 2025 | ☀ PRE | $0.96 | $0.97 | $0.95 | 9,995 | -6.86% | open_in_new |
| Mar 24, 2025 | ☽ POST | $1.38 | $1.44 | $1.38 | 2,755 | -4.35% | open_in_new |
| Nov 13, 2024 | ☽ POST | $1.68 | $1.68 | $1.61 | 6,251 | +18.89% | open_in_new |
| Aug 13, 2024 | ☽ POST | $0.71 | $0.71 | $0.57 | 37,347 | -3.73% | open_in_new |
| Jul 24, 2023 | ☀ PRE | $1.35 | $1.35 | $1.23 | 94,282 | -25% | open_in_new |
| Jan 30, 2023 | ☽ POST | $0.88 | $1.01 | $1.00 | 5,685 | -1.2% | open_in_new |
| Aug 01, 2022 | ☀ PRE | $2.00 | $2.03 | $2.02 | 1,579 | +4.65% | open_in_new |
| May 12, 2022 | ☽ POST | $3.06 | $3.36 | $3.36 | 26,363 | +0.89% | open_in_new |
| Feb 02, 2022 | ☽ POST | $6.58 | $6.58 | $6.12 | 22,608 | -7.84% | open_in_new |
Earnings Count
12
Total earnings in dataset
Avg Abs. Movement
±12.77%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
5 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| SCHEDULE 13G | 20260610 | open_in_new SEC.gov |
| 8-K | 20260521 | open_in_new SEC.gov |
| 8-K/A | 20260518 | open_in_new SEC.gov |
| 8-K | 20260518 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260515 | open_in_new SEC.gov |
Frequently asked about QNCX earnings
When does Quince Therapeutics, Inc. Common Stock report earnings next? expand_more
Quince Therapeutics, Inc. Common Stock (QNCX)'s next earnings date is predicted (high confidence) for 2026-07-15. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does QNCX stock move after earnings? expand_more
Over 12 reports, QNCX has moved an average of ±12.77% the session after earnings, closing higher 33.3% of the time.
What was QNCX's biggest post-earnings move? expand_more
QNCX's largest post-earnings gain on record was +18.89% on Nov 13, 2024, and its largest decline was -61.49% on Feb 12, 2026.
Where can I find Quince Therapeutics, Inc. Common Stock's SEC filings? expand_more
All of Quince Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right